GR3019505T3 - Sustained-release pharmaceutical preparation and process for preparing the same - Google Patents

Sustained-release pharmaceutical preparation and process for preparing the same

Info

Publication number
GR3019505T3
GR3019505T3 GR960400893T GR960400893T GR3019505T3 GR 3019505 T3 GR3019505 T3 GR 3019505T3 GR 960400893 T GR960400893 T GR 960400893T GR 960400893 T GR960400893 T GR 960400893T GR 3019505 T3 GR3019505 T3 GR 3019505T3
Authority
GR
Greece
Prior art keywords
pharmaceutical preparation
release pharmaceutical
same
preparing
heat
Prior art date
Application number
GR960400893T
Other languages
English (en)
Inventor
Kazuo Noda
Masao Kobayashi
Takashi Osawa
Toru Maejima
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of GR3019505T3 publication Critical patent/GR3019505T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960400893T 1991-04-08 1996-04-02 Sustained-release pharmaceutical preparation and process for preparing the same GR3019505T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3075335A JP2538134B2 (ja) 1991-04-08 1991-04-08 徐放性製剤およびその製造法

Publications (1)

Publication Number Publication Date
GR3019505T3 true GR3019505T3 (en) 1996-07-31

Family

ID=13573284

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400893T GR3019505T3 (en) 1991-04-08 1996-04-02 Sustained-release pharmaceutical preparation and process for preparing the same

Country Status (13)

Country Link
US (1) US5389380A (el)
EP (1) EP0508653B1 (el)
JP (1) JP2538134B2 (el)
KR (1) KR0156943B1 (el)
AT (1) ATE133333T1 (el)
CA (1) CA2064150A1 (el)
DE (1) DE69207799T2 (el)
DK (1) DK0508653T3 (el)
ES (1) ES2082364T3 (el)
GR (1) GR3019505T3 (el)
HK (1) HK1003327A1 (el)
IE (1) IE71680B1 (el)
TW (1) TW223592B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
HU218673B (hu) * 1993-10-07 2000-10-28 Euroceltique S.A. Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
JP5042447B2 (ja) * 1995-07-21 2012-10-03 第一三共株式会社 混合製剤
JP4260370B2 (ja) 1998-08-10 2009-04-30 旭化成ファーマ株式会社 塩酸ファスジルの経口徐放性製剤
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
DE19933289A1 (de) * 1999-07-15 2001-01-18 Basf Ag Verfahren zur Herstellung eines Granulats aus einer Schmelze
US6254888B1 (en) * 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
JP4355925B2 (ja) 2002-02-21 2009-11-04 大塚製薬株式会社 徐放製剤及びその製造方法
WO2005039537A1 (en) 2003-10-22 2005-05-06 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery
US8188067B2 (en) 2004-04-01 2012-05-29 Teva Pharmaceutical Industries Ltd. Formulations of 6-mercaptopurine
EP1729727B1 (en) * 2004-04-01 2019-07-03 Hadasit Medical Research Services and Development Ltd. Improved formulations of 6-mercaptopurine
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
WO2006090845A1 (ja) * 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited 顆粒の製造方法
US9693967B2 (en) * 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
WO2009128955A1 (en) * 2008-04-18 2009-10-22 Teva Pharmaceutical Industries Ltd. Treatment of inflammatory bowel disease with 6-mercaptopurine
DE102010001620A1 (de) * 2010-02-05 2011-08-11 Siemens Aktiengesellschaft, 80333 Ständer einer permanenterregten rotierenden elektrischen Maschine
US9492395B2 (en) 2010-05-11 2016-11-15 Sensient Colors Llc Film coating composition and methods of making and using the same
US20170105996A1 (en) 2015-10-16 2017-04-20 Teva Pharmaceutical Industries, Ltd. Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine
KR102000073B1 (ko) 2018-12-26 2019-07-16 주식회사 우드메탈 가구용 높낮이조절 받침장치

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171918A (en) 1981-04-17 1982-10-22 Eisai Co Ltd Theophyllin gradually releasing composition
JPS58214333A (ja) 1982-06-04 1983-12-13 Dai Ichi Seiyaku Co Ltd 粒状物
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
JPH066532B2 (ja) * 1983-09-29 1994-01-26 日産化学工業株式会社 親水性コロイドにより変性したワックス性微粉末
US4853249A (en) * 1985-11-15 1989-08-01 Taisho Pharmaceutical Co., Ltd. Method of preparing sustained-release pharmaceutical/preparation
JPH0764726B2 (ja) 1985-11-15 1995-07-12 大正製薬株式会社 持効性製剤の製造方法
JPH0647531B2 (ja) 1986-02-06 1994-06-22 第一製薬株式会社 徐放性粒状物の製造法
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPS6327424A (ja) 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
GB8707740D0 (en) * 1987-04-01 1987-05-07 Strathclyde Minerals Ltd Composition
JP2668880B2 (ja) * 1987-06-23 1997-10-27 日本油脂株式会社 被覆アミノ酸類の製造方法
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta

Also Published As

Publication number Publication date
EP0508653B1 (en) 1996-01-24
IE71680B1 (en) 1997-02-26
JP2538134B2 (ja) 1996-09-25
EP0508653A1 (en) 1992-10-14
KR0156943B1 (ko) 1998-11-16
KR920019339A (ko) 1992-11-19
JPH04312524A (ja) 1992-11-04
ES2082364T3 (es) 1996-03-16
TW223592B (el) 1994-05-11
US5389380A (en) 1995-02-14
DK0508653T3 (da) 1996-06-10
DE69207799T2 (de) 1996-05-30
IE920954A1 (en) 1992-10-21
ATE133333T1 (de) 1996-06-10
CA2064150A1 (en) 1992-10-09
DE69207799D1 (de) 1996-03-07
HK1003327A1 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
HK1003327A1 (en) Sustained-release pharmaceutical preparation and process for preparing the same
CA2016039A1 (en) Extended release pharmaceutical formulations
HUT70851A (en) Organic salts of n,n`-diacetyl-cystine, pharmaceutical compositions containing them and process for preparing them
LTIP656A (en) Derivatives of 3-amidopyrazole, process for preparing thereof and pharmaceutical composition containing them
HUT63407A (en) Process for producing substituted indole, indene, piranoindole and tetrahydrocarbazole alkanoic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT61285A (en) Process for producing new condensed imidazole derivatives and pharmaceutical compositions comprising such compounds
HUT70157A (en) Imidazolylalcenoic acids, pharmaceutical compositions containing them, and process for producing them, and use of them for preparing medicaments
HUP0004050A2 (hu) Javított oldódású itrakonazol, eljárás ennek előállítására és ezt tartalmazó orális gyógyszerkészítmény
HUT61751A (en) Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT56270A (en) Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient
ZA915717B (en) Benzimidazoles,pharmaceutical compositions containing these compounds and processes for preparing them
DE59104271D1 (de) Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung.
FI914354A (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
FR2688405B1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
DE69103922D1 (de) Verfahren zur Herstellung arzneistoffhaltiger Tabletten mit verzögerter Freigabe.
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53109A (en) Process for producing benzodiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HU901579D0 (en) Process for the preparation of substituted /quinolin-2-yl-methoxy/-phenyl-n'n-sulfonyl-ureas and pharmaceutical compositions containing such compounds
HUT61724A (en) Process for producing cycloalkylurea compounds and pharmaceutical compositions comprising such active ingredient
HUT61740A (en) Process for producing 2-piperidinyl-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient